APM
ORGO icon

Avidity Partners Management’s Organogenesis Holdings ORGO Stock Holding History

Avidity Partners Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,463,403
Closed -$26.7M – 136
2021
Q1 		$26.7M Sell
1,463,403
-4,058,097
-73% -$55M 0.74% 48
2020
Q4 		$41.6M Buy
+5,521,500
New +$26.2M 1.35% 25

Other funds holding ORGO

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NMIMC
Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $8.53B AUM 25.12% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Avidity Partners Management's ORGO Position: Q2 2021 in Review

Avidity Partners Management sold out of Organogenesis Holdings (ORGO) in Q2 2021, closing a stake of 1,463,403 shares — an estimated $26.7M sold.

Avidity Partners Management first reported a position in ORGO in Q4 2020 and held it in 2 quarters. The position peaked at $41.6M in Q4 2020. 143 funds tracked by Wall St. Rank hold ORGO as of Q2 2021.

  • Avidity Partners Management reported no remaining Organogenesis Holdings position as of Q2 2021 after selling out during the quarter.
  • Avidity Partners Management sold 1,463,403 Organogenesis Holdings shares in Q2 2021, an estimated $26.7M.
  • Avidity Partners Management first reported a position in Organogenesis Holdings in Q4 2020 and held it in 2 quarters.
  • Avidity Partners Management's Organogenesis Holdings position peaked at $41.6M in Q4 2020.
  • 143 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2021.

Based on Avidity Partners Management's 13F filing for Q2 2021, filed 16 Aug 2021.